Detection of transforming growth factor-β1 in human plasma - A pilot study on breast cancer patients

Jugoslovenska Medicinska Biokemija

Volumn 20, Issue 2, 2001, Pages 81-87

  Ivanovic V ^a   Todorovic Rakovic N ^a   Demajo, M ^a   Neskovic Konstantinovic Z ^a   Nikolic Vukosavljevic D ^a   Ivanisevic Milovanovic O ^a   Mitrovic L ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Breast cancer; Plasma biomarkers; Protease inhibitors; TGF 1

Indexed keywords

APROTININ; BENZYLSULFONYL FLUORIDE; BREAST; CANCER CELL; CONCENTRATION (PARAMETERS); ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC MARKER; PROTEIN DETECTION; PROTEINASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0034970297     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Overview of the biologic markers of breast cancer
2. How to integrate serum tumor markers into clinical oncologic practice
3. Tumor markers - An overview
4. Serum (circulating) tumor markers for breast cancer: Recent results
5. Increased cathepsin D level in the serum of patients with metastatic breast carcinoma detected with a specific procathepsin D immunoassay
6. 1 expression in human colorectal tumours: An independent prognostic marker in a subgroup of poor prognosis patients
7. 1 in patients with colorectal cancer: Association with disease progression
8. Transforming growth factor-β isoforms expressions in pulmonary adenocarcinomas as prognostic markers
9. Transforming growth factor-β: A general review
10. Transforming growth factor-β: Biological function and chemical structure
11. Genetic events and the role of TGF beta in epithelial tumour progression
12. 1 in ductal carcinoma in situ and invasive carcinoma of the breast
13. 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma
14. 1 associates with disease progression in human breast cancer
15. 1 in patients with hepatocellular carcinoma
16. 1 in patients with invasive prostate cancer
17. 1 as a prognostic biomarker of prostate carcinoma
18. 1 in renal cell carcinoma
19. 1) in breast carcinogenesis
20. 1 and second primary breast cancer in a chemoprevention trial
21. Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer
22. TGF-beta 1 levels in pretreatment plasma identify breast cancer patients at risk of developing postradiotherapy fibrosis
23. 1 circulates in normal human plasma and is unchanged in advanced metastatic breast cancer
24. Biological and clinical significance of cathepsin D in breast cancer
25. Thrombospondin-1 and transforming growth factor-beta1 promote breast tumor cell invasion through up-regulation of the plasminogen/plasmin system
26. 1 in blood: A complex problem
27. 1) in blood; assay development and comparison
28. Release and activation of platelet latent TGF-β in blood clots during dissolution with plasmin
29. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization